Gavi should stop awarding special funds to Pfizer and GSK for pneumonia vaccine
More children can be protected against the number one childhood killer disease if Gavi reserves its special funding to promote a new affordable version of pneumonia vaccine Doctors Wwithout Borders (MSF) urges Gavi, the Vaccine Alliance to reserve its remaining funds for pneumonia vaccine under the Advanced Market Commitment (AMC) for a new manufacturer…